Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners-Reference-Cited by-同舟云学术

Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners

Published:2019-03 Issue:3 Volume:22 Page:e25260
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Henderson Gail E¹,Waltz Margaret¹,Meagher Karen²,Cadigan R Jean¹,Jupimai Thidarat³,Isaacson Sinéad¹,Ormsby Nuchanart Q¹,Colby Donn J⁴,Kroon Eugène⁴,Phanuphak Nittaya⁴,Ananworanich Jintanat⁴⁵⁶,Peay Holly L⁷

Affiliation:

1. Social Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA

2. Biomedical Ethics Research Program Mayo Clinic Rochester MN USA

3. Center of Excellence in Pediatric Infectious Diseases and Vaccines Chulalongkorn University Bangkok Thailand

4. SEARCH, Thai Red Cross AIDS Research Centre Bangkok Thailand

5. U.S. Military HIV Research Program Walter Reed Army Institute of Research Silver Spring MD USA

6. Henry M. Jackson Foundation for the Advancement of Military Medicine Bethesda MD USA

7. RTI International Research Triangle Park NC USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25260

Reference22 articles.

1. Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection

2. What motivates participation in HIV cure trials? A call for real‐time assessment to improve informed consent;Peay HL;J Virus Erad,2015

3. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment;Henderson GE;J Med Ethics,2018

4. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

5. Dynamics of HIV viremia and antibody seroconversion in plasma donors

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States;HIV RES CLIN PRACT;2024

2. People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research;AIDS;2023-10-17

3. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States;HIV RES CLIN PRACT;2023

4. The Essential Need for Trust When Transmission Risk Cannot Be Eliminated in HIV‐Remission Trials;Ethics & Human Research;2023-06-27

5. The Importance of Social Engagement in the Development of an HIV Cure: A Systematic Review of Stakeholder Perspectives;AIDS and Behavior;2023-06-17